Launching in today’s unpredictable market is a journey with new challenges around every corner. While product pipelines are rapidly growing, stringent competition and an evolving provider environment are putting intense pressure on manufacturers to build effective commercialization infrastructures, think globally and launch products at unprecedented speeds, which comes at a steep price.

In this session, innovators in oncology, rare and infectious disease share their journeys to global commercialization and launch excellence. They share their experiences of leveraging innovative, integrated and streamlined models to maximize brand value and improve patient access and outcomes.

Speakers

Mike Ryan, General Manager, Europe EVERSANA [Moderator]
Bhavesh Ashar, Chief Commercial Officer SpringWorks Therapeutics
Marc Brumagne, Global Commercial Operations HIV Gilead
Sharon Cunningham, Chief Executive Officer Shorla Oncology